Oct
2026
Fiera Milano, Italy
Visit us
stand 10F37, CRO
ChemExpress
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2022
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 10F37, CRO
Products Featured at CPHI Milan 2026
-
Product (R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid
(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid is an organic compound containing a tert-butoxycarbonyl (Boc) protecting group, primarily used as a pharmaceutical intermediate. This compound introduces a tert-butoxycarbonyl group to the amino group to protect it, ens... -
Product 2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
The melting point of 2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one is between 176°C and 178°C, with a density of 1.3. Under normal temperature and pressure, it appears as a yellow or dark yellow solid. Its solubility in chloroform and methanol is moderate, but it dissolves better when hea... -
Product 2'-Fluoro-2'-deoxycytidine
2'-Deoxy-2'-fluorocytidine can synergize with T705 to enhance the antiviral efficacy of both compounds against CCHFV replication, and is widely used in the development of antiviral bioactive molecules and drug molecules. Firstly, it has garnered significant attention as an effective inhibitor of Crimean-Co... -
Product 2'-Fluoro-2'-deoxyuridine
2'-氟-2'-脱氧尿苷 -
Product 4,6-dichloro-2-propylthiopyrimidine-5-amine
4,6-Dichloro-2-(propylthio)-5-aminopyrimidine is a pharmaceutical intermediate that can be used as an intermediate for ticagrelor, an antithrombotic drug; it is a ticagrelor intermediate.
Shanghai Haoyuan ChemExpress Co., Ltd. Resources (1)
-
Video ChemExpress One-stop CRO & CDMO Service
Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.
![(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid](https://www.cphi-online.com/img/v2021/product_image.png)
